Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea
Sponsor: Eisai Inc.
A PHASE1 clinical study on Healthy Subjects and Obstructive Sleep Apnea, this trial is completed. The trial is conducted by Eisai Inc. and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Completed PHASE1
▶ Show 3 earlier versions
-
Nov 2018 — Feb 2020 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Aug 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2018 — Aug 2018 [monthly]
Recruiting PHASE1
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eisai Inc.
- Purdue Pharma LP
For direct contact, visit the study record on ClinicalTrials.gov .